AWARD
99 -- Oral Mucosal Vaccine for SARS-CoV2 Protection
- Notice Date
- 1/13/2024 11:59:17 AM
- Notice Type
- Award Notice
- Contracting Office
- ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Solicitation Number
- 75A50124C00002
- Archive Date
- 01/27/2024
- Point of Contact
- richard hall
- E-Mail Address
-
richard.hall@hhs.gov
(richard.hall@hhs.gov)
- Award Number
- 75A50124C00002
- Award Date
- 01/12/2024
- Awardee
- VAXART BIOSCIENCES INC South San Francisco CA 94080 USA
- Award Amount
- 9271193.00
- Description
- Oral Covid-19 XBB vaccine candidate as a/an tableted prophylactic vaccine� for the treatment of SARS-CoV2. The scope of work for this contract encompasses the completion of the planning of and preparation for a phase 2b clinical trial.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/c9e655fc3c514e6da562fa02948a4a6b/view)
- Place of Performance
- Address: San Francisco, CA, USA
- Country: USA
- Country: USA
- Record
- SN06935114-F 20240115/240113230034 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |